Abstract
Fungal pathogens of the genus Candida form biofilms on catheters and prosthetic devices. These threedimensional structures composed of yeast and hyphal cells embedded in an extracellular matrix constitute an important pitfall in the management of disseminated Candida infections because of their intrinsic resistance to almost all antifungals in clinical use. Candida biofilms are especially resistant to azoles and amphotericin B but remain sensitive to the newly introduced echinocandins that target cell wall β-glucan biosynthesis. Antifungal resistance of biofilms results most probably from the conjunction of several mechanisms that act in a time-dependent manner. While drug efflux is likely to contribute to resistance during the early phases of biofilm formation, changes in the sterol composition of membranes might explain the resistance of mature biofilms. The original physiology of mature Candida biofilms is mirrored by specific gene expression patterns that may pinpoint genes important for the acquisition of pleiotropic antifungal resistance.
Keywords: Biofilm, azole, caspofungin, echinocandin, amphotericin B, multi-drug resistance, efflux, sterol
Current Drug Targets
Title: Biofilms and their Role in the Resistance of Pathogenic Candida to Antifungal Agents
Volume: 7 Issue: 4
Author(s): Christophe d'Enfert
Affiliation:
Keywords: Biofilm, azole, caspofungin, echinocandin, amphotericin B, multi-drug resistance, efflux, sterol
Abstract: Fungal pathogens of the genus Candida form biofilms on catheters and prosthetic devices. These threedimensional structures composed of yeast and hyphal cells embedded in an extracellular matrix constitute an important pitfall in the management of disseminated Candida infections because of their intrinsic resistance to almost all antifungals in clinical use. Candida biofilms are especially resistant to azoles and amphotericin B but remain sensitive to the newly introduced echinocandins that target cell wall β-glucan biosynthesis. Antifungal resistance of biofilms results most probably from the conjunction of several mechanisms that act in a time-dependent manner. While drug efflux is likely to contribute to resistance during the early phases of biofilm formation, changes in the sterol composition of membranes might explain the resistance of mature biofilms. The original physiology of mature Candida biofilms is mirrored by specific gene expression patterns that may pinpoint genes important for the acquisition of pleiotropic antifungal resistance.
Export Options
About this article
Cite this article as:
d'Enfert Christophe, Biofilms and their Role in the Resistance of Pathogenic Candida to Antifungal Agents, Current Drug Targets 2006; 7 (4) . https://dx.doi.org/10.2174/138945006776359458
DOI https://dx.doi.org/10.2174/138945006776359458 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Infection and Anemia
Infectious Disorders - Drug Targets Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews Oral Factor Xa (FXa) Inhibitors for Treatment of Heparin-induced Thrombocytopenia (HIT)
Current Drug Therapy Allergic Bronchopulmonary Aspergillosis: AllA Radiologist Needs To Know
Current Pediatric Reviews New Developments in Therapeutic Agents for Legionnaires Disease
Anti-Infective Agents in Medicinal Chemistry Antibiotic Prophylaxis in Urologic Prosthetic Surgery
Current Pharmaceutical Design Quorum Sensing Inhibitors from the Sea: Lessons from Marine Symbiotic Relationships
Current Organic Chemistry Brucella Pneumonia with Systemic Complications and Pancytopenia: A Case Report
Infectious Disorders - Drug Targets Antimicrobial Peptides as Anti-biofilm Agents in Medical Implants
Current Topics in Medicinal Chemistry Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?
Current Cardiology Reviews Brucella as a Potential Agent of Bioterrorism
Recent Patents on Anti-Infective Drug Discovery Novel Therapeutic Agents for Resistant Gram-Positive Infections
Current Drug Therapy Atherosclerotic and Non-Atherosclerotic Coronary Heart Disease in Women
Current Medicinal Chemistry Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Perceval Sutureless Valve – are Sutureless Valves Here?
Current Cardiology Reviews The Importance of Guidelines in the Development and Application of Probiotics
Current Pharmaceutical Design New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design Small Molecule Approaches Toward the Non-Microbicidal Modulation of Bacterial Biofilm Growth and Maintenance
Anti-Infective Agents in Medicinal Chemistry Therapeutic Modulation of Cytokines in Chronic Infectious Diseases
Current Pharmaceutical Design Postoperative Complications in Hemorrhoidal Disease and Special Conditions
Reviews on Recent Clinical Trials